Out-of-pocket costs for infliximab and its biosimilar for rheumatoid arthritis under medicare part d

Jinoos Yazdany, R. Adams Dudley, Grace A. Lin, Randi Chen, Chien Wen Tseng

Research output: Contribution to journalLetterpeer-review

22 Scopus citations
Original languageEnglish (US)
Pages (from-to)931-933
Number of pages3
JournalJAMA - Journal of the American Medical Association
Issue number9
StatePublished - Sep 4 2018
Externally publishedYes

Bibliographical note

Funding Information:
Funding/Support: This study was funded by grant R03HS016772 from the Agency for Healthcare Research and Quality (Dr Tseng), grant NIH/NIAMS P30 AR070155 from the Robert L. Kroc Endowed Chair in Rheumatic and Connective Tissue Diseases (Dr Yazdany), the Hawaii Medical Services Association Endowed Chair in Health Services and Quality Research at the University of Hawaii (Dr Tseng), and the Russell/Engleman Medical Research Center for Arthritis at the University of California, San Francisco (Dr Yazdany).

Cite this